Skip to content

Drug interactions

Metformin-repaglinide + Selegiline

Severity: Minor

Metformin-repaglinide and Selegiline: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Selegiline, an MAO-B inhibitor, has no well-established pharmacokinetic interaction with metformin. MAO inhibitors may enhance hypoglycemic effects of antidiabetic agents, which could matter for repaglinide.

What this interaction means in plain words

Metformin-repaglinide and Selegiline have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Metformin-repaglinide belongs to Endocrine; Selegiline belongs to Central Nervous System.

Evidence level: Low

Why it happens

The mechanism is not well established; MAO inhibition may enhance insulin sensitivity or hypoglycemia.

What to do

Monitor blood glucose when starting or stopping selegiline and adjust antidiabetic doses if hypoglycemia occurs.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Metformin-repaglinide and Selegiline, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Metformin-repaglinide with Selegiline?

MediHelp rates the interaction as minor. Metformin-repaglinide and Selegiline have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Selegiline, an MAO-B inhibitor, has no well-established pharmacokinetic interaction with metformin. MAO inhibitors may enhance hypoglycemic effects of antidiabetic agents, which could matter for repaglinide.

How serious is the interaction between Metformin-repaglinide and Selegiline?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose when starting or stopping selegiline and adjust antidiabetic doses if hypoglycemia occurs.

What other medicines interact with Metformin-repaglinide?

MediHelp also lists interactions of Metformin-repaglinide with, for example, Gemfibrozil, Apalutamide, Clarithromycin. The full list is on the Metformin-repaglinide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in